Investors

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.

Latest News


Race Develops Improved IV Formulation of Zantrene

To discuss or comment on this announcement please visit our Investor Hub.

Race Initiates FTO & ALKBH5 Drug Discovery Program

To discuss or comment on this announcement please visit our Investor Hub.

Race Oncology 2022 Annual Report

Race Oncology June 2022 Quarterly Investor Briefing
Race Oncology June 2022 Quarterly Investor Briefing

Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race’s June 2022 Quarterly I…

June 2022 Quarterly Activity Report